MRI-guided brain stimulation for Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests a new non-invasive brain stimulation method guided by MRI to see if it can improve Parkinson's symptoms. It may be an option for people who respond well to their current Parkinson's medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with Parkinson's disease and are at a certain stage (2 to 4).
- Your symptoms improve by more than a third after taking your Parkinson's medication.
- You have been on the same Parkinson's medications for at least 4 weeks before starting.
- You do not have significant memory or thinking problems.
- You have no metal implants in your brain or body and are not claustrophobic, since the procedure uses MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new, noninvasive brain stimulation technique (called temporal interference stimulation) given at different frequencies. It aims to improve Parkinson's symptoms by gently stimulating the brain area involved in movement.
This trial tests a new, non-invasive brain stimulation technique (called temporal interference stimulation) to see if it can improve Parkinson's symptoms. It uses MRI to guide the treatment, and the goal is to help with movement and other symptoms without surgery.
This trial tests a new type of brain stimulation (called temporal interference stimulation) targeted at specific brain regions to help improve Parkinson's disease symptoms. Researchers will use MRI imaging and behavioral assessments to see if this approach can reduce movement problems and improve quality of life.
This trial tests a new non-invasive brain stimulation method called temporal interference to see if it can improve symptoms of Parkinson's disease. It is for people aged 40 to 80 who are on stable Parkinson's medications and have mild to moderate symptoms.
This trial tests a non-invasive brain stimulation technique (using electrical currents applied through the scalp) aimed at the subthalamic nucleus—a brain region involved in movement control—to help reduce both movement-related symptoms (like tremor and stiffness) and non-movement symptoms (like mood and sleep problems) in people with Parkinson's disease.
This trial uses a new type of non-invasive brain stimulation to target a deep brain area that controls movement. It aims to improve motor symptoms like stiffness and slowness in people with Parkinson's disease, without needing surgery.
Hear when a new Parkinson Disease (PD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.